How big is the Glucagon Market?

The Glucagon Market size is expected to reach USD 576.13 million in 2024 and grow at a CAGR of 6.03% to reach USD 772.75 million by 2029. Read More

What is the current Glucagon Market size?

In 2024, the Glucagon Market size is expected to reach USD 576.13 million. Read More

Who are the key players in Glucagon Market?

Amphastar Pharmaceuticals, Inc, Xeris Biopharma Holdings, Inc, Novo Nordisk A/S, Zealand Pharma A/S and Fresenius SE & Co. KGaA are the major companies operating in the Glucagon Market. Read More

Which is the fastest growing region in Glucagon Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Glucagon Market?

In 2024, the North America accounts for the largest market share in Glucagon Market. Read More

What years does this Glucagon Market cover, and what was the market size in 2023?

In 2023, the Glucagon Market size was estimated at USD 541.39 million. The report covers the Glucagon Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Glucagon Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Glucagon Market Size & Share Analysis - Industry Research Report

Glucagon Market - Growth, Trends, and Forecasts (2024-2029)

The Glucagon Market Report is Segmented by Route of Administration (Injection and Inhalation), Application (Hypoglycemia and Diagnostic Aid), Distribution Channel (Online and Offline), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The Report Offers the Value (USD) for the Above Segments.

Glucagon Industry Overview

The glucagon market is consolidated in nature due to the dominance of some players operating globally. The competitive landscape includes an analysis of a few international and local companies which hold substantial market share. Some of them are Xeris Biopharma Holdings Inc., Novo Nordisk A/S, Amphastar Pharmaceuticals Inc., Zealand Pharma A/S Co. Ltd, Arecor, Fresenius SE & Co. KGaA, Taj Pharmaceuticals Limited, ILS Inc., United Biotech (P) Limited, and Avalon Pharma Private Limited.